Sample Request

Global Non–Invasive Prenatal Testing Market Report 2020 by Key Players, Types, Applications, Countries, Market Size, Forecast to 2026 (Based on 2020 COVID-19 Worldwide Spread)

SELECT LICENSE:

Published on 09/01/2020| Code: MAR41115D| Category: Utilities| Total Pages: 119

The Non–Invasive Prenatal Testing market is expected to grow from USD X.X million in 2020 to USD X.X million by 2026, at a CAGR of X.X% during the forecast period. The global Non–Invasive Prenatal Testing market report is a comprehensive research that focuses on the overall consumption structure, development trends, sales models and sales of top countries in the global Non–Invasive Prenatal Testing market. The report focuses on well-known providers in the global Non–Invasive Prenatal Testing industry, market segments, competition, and the macro environment.

Under COVID-19 Outbreak, how the Non–Invasive Prenatal Testing Industry will develop is also analyzed in detail in Chapter 1.7 of the report.

In Chapter 2.4, we analyzed industry trends in the context of COVID-19.

In Chapter 3.5, we analyzed the impact of COVID-19 on the product industry chain based on the upstream and downstream markets.

In Chapters 6 to 10 of the report, we analyze the impact of COVID-19 on various regions and major countries.

In chapter 13.5, the impact of COVID-19 on the future development of the industry is pointed out.

A holistic study of the market is made by considering a variety of factors, from demographics conditions and business cycles in a particular country to market-specific microeconomic impacts. The study found the shift in market paradigms in terms of regional competitive advantage and the competitive landscape of major players.

Key players in the global Non–Invasive Prenatal Testing market covered in Chapter 4:

Koninklijke Philips N.V.
Ariosa Diagnostics
Premaitha Health PLC
F. Hoffmann-La Roche Ltd.
GE Healthcare
Thermo Fisher Scientific, Inc.
Illumina, Inc.
LifeCodexx AG
NIPD Genetics

In Chapter 11 and 13.3, on the basis of types, the Non–Invasive Prenatal Testing market from 2015 to 2026 is primarily split into:

Consumables
Reagent
Ultrasound
NGS
PCR
Microarray

In Chapter 12 and 13.4, on the basis of applications, the Non–Invasive Prenatal Testing market from 2015 to 2026 covers:

Aneuploidy
Microdeletion

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2026) of the following regions are covered in Chapter 5, 6, 7, 8, 9, 10, 13:

North America (Covered in Chapter 6 and 13)

United States

Canada

Mexico

Europe (Covered in Chapter 7 and 13)

Germany

UK

France

Italy

Spain

Russia

Others

Asia-Pacific (Covered in Chapter 8 and 13)

China

Japan

South Korea

Australia

India

Southeast Asia

Others

Middle East and Africa (Covered in Chapter 9 and 13)

Saudi Arabia

UAE

Egypt

Nigeria

South Africa

Others

South America (Covered in Chapter 10 and 13)

Brazil

Argentina

Columbia

Chile

Others

Years considered for this report:

Historical Years: 2015-2019

Base Year: 2019

Estimated Year: 2020

Forecast Period: 2020-2026

Table of Content

1 Report Overview

1.1 Study Scope

1.2 Key Market Segments

1.3 Regulatory Scenario by Region/Country

1.4 Market Investment Scenario Strategic

1.5 Market Analysis by Type

1.5.1 Global Non–Invasive Prenatal Testing Market Share by Type (2020-2026)

1.5.2 Consumables
1.5.3 Reagent
1.5.4 Ultrasound
1.5.5 NGS
1.5.6 PCR
1.5.7 Microarray
1.6 Market by Application

1.6.1 Global Non–Invasive Prenatal Testing Market Share by Application (2020-2026)

1.6.2 Aneuploidy
1.6.3 Microdeletion
1.7 Non–Invasive Prenatal Testing Industry Development Trends under COVID-19 Outbreak

1.7.1 Global COVID-19 Status Overview

1.7.2 Influence of COVID-19 Outbreak on Non–Invasive Prenatal Testing Industry Development

2. Global Market Growth Trends

2.1 Industry Trends

2.1.1 SWOT Analysis

2.1.2 Porter’s Five Forces Analysis

2.2 Potential Market and Growth Potential Analysis

2.3 Industry News and Policies by Regions

2.3.1 Industry News

2.3.2 Industry Policies

2.4 Industry Trends Under COVID-19

3 Value Chain of Non–Invasive Prenatal Testing Market

3.1 Value Chain Status

3.2 Non–Invasive Prenatal Testing Manufacturing Cost Structure Analysis

3.2.1 Production Process Analysis

3.2.2 Manufacturing Cost Structure of Non–Invasive Prenatal Testing

3.2.3 Labor Cost of Non–Invasive Prenatal Testing

3.2.3.1 Labor Cost of Non–Invasive Prenatal Testing Under COVID-19

3.3 Sales and Marketing Model Analysis

3.4 Downstream Major Customer Analysis (by Region)

3.5 Value Chain Status Under COVID-19

4 Players Profiles

4.1 Koninklijke Philips N.V.
4.1.1 Koninklijke Philips N.V. Basic Information
4.1.2 Non–Invasive Prenatal Testing Product Profiles, Application and Specification
4.1.3 Koninklijke Philips N.V. Non–Invasive Prenatal Testing Market Performance (2015-2020)
4.1.4 Koninklijke Philips N.V. Business Overview
4.2 Ariosa Diagnostics
4.2.1 Ariosa Diagnostics Basic Information
4.2.2 Non–Invasive Prenatal Testing Product Profiles, Application and Specification
4.2.3 Ariosa Diagnostics Non–Invasive Prenatal Testing Market Performance (2015-2020)
4.2.4 Ariosa Diagnostics Business Overview
4.3 Premaitha Health PLC
4.3.1 Premaitha Health PLC Basic Information
4.3.2 Non–Invasive Prenatal Testing Product Profiles, Application and Specification
4.3.3 Premaitha Health PLC Non–Invasive Prenatal Testing Market Performance (2015-2020)
4.3.4 Premaitha Health PLC Business Overview
4.4 F. Hoffmann-La Roche Ltd.
4.4.1 F. Hoffmann-La Roche Ltd. Basic Information
4.4.2 Non–Invasive Prenatal Testing Product Profiles, Application and Specification
4.4.3 F. Hoffmann-La Roche Ltd. Non–Invasive Prenatal Testing Market Performance (2015-2020)
4.4.4 F. Hoffmann-La Roche Ltd. Business Overview
4.5 GE Healthcare
4.5.1 GE Healthcare Basic Information
4.5.2 Non–Invasive Prenatal Testing Product Profiles, Application and Specification
4.5.3 GE Healthcare Non–Invasive Prenatal Testing Market Performance (2015-2020)
4.5.4 GE Healthcare Business Overview
4.6 Thermo Fisher Scientific, Inc.
4.6.1 Thermo Fisher Scientific, Inc. Basic Information
4.6.2 Non–Invasive Prenatal Testing Product Profiles, Application and Specification
4.6.3 Thermo Fisher Scientific, Inc. Non–Invasive Prenatal Testing Market Performance (2015-2020)
4.6.4 Thermo Fisher Scientific, Inc. Business Overview
4.7 Illumina, Inc.
4.7.1 Illumina, Inc. Basic Information
4.7.2 Non–Invasive Prenatal Testing Product Profiles, Application and Specification
4.7.3 Illumina, Inc. Non–Invasive Prenatal Testing Market Performance (2015-2020)
4.7.4 Illumina, Inc. Business Overview
4.8 LifeCodexx AG
4.8.1 LifeCodexx AG Basic Information
4.8.2 Non–Invasive Prenatal Testing Product Profiles, Application and Specification
4.8.3 LifeCodexx AG Non–Invasive Prenatal Testing Market Performance (2015-2020)
4.8.4 LifeCodexx AG Business Overview
4.9 NIPD Genetics
4.9.1 NIPD Genetics Basic Information
4.9.2 Non–Invasive Prenatal Testing Product Profiles, Application and Specification
4.9.3 NIPD Genetics Non–Invasive Prenatal Testing Market Performance (2015-2020)
4.9.4 NIPD Genetics Business Overview

5 Global Non–Invasive Prenatal Testing Market Analysis by Regions

5.1 Global Non–Invasive Prenatal Testing Sales, Revenue and Market Share by Regions

5.1.1 Global Non–Invasive Prenatal Testing Sales by Regions (2015-2020)

5.1.2 Global Non–Invasive Prenatal Testing Revenue by Regions (2015-2020)

5.2 North America Non–Invasive Prenatal Testing Sales and Growth Rate (2015-2020)

5.3 Europe Non–Invasive Prenatal Testing Sales and Growth Rate (2015-2020)

5.4 Asia-Pacific Non–Invasive Prenatal Testing Sales and Growth Rate (2015-2020)

5.5 Middle East and Africa Non–Invasive Prenatal Testing Sales and Growth Rate (2015-2020)

5.6 South America Non–Invasive Prenatal Testing Sales and Growth Rate (2015-2020)

6 North America Non–Invasive Prenatal Testing Market Analysis by Countries

6.1 North America Non–Invasive Prenatal Testing Sales, Revenue and Market Share by Countries

6.1.1 North America Non–Invasive Prenatal Testing Sales by Countries (2015-2020)

6.1.2 North America Non–Invasive Prenatal Testing Revenue by Countries (2015-2020)

6.1.3 North America Non–Invasive Prenatal Testing Market Under COVID-19

6.2 United States Non–Invasive Prenatal Testing Sales and Growth Rate (2015-2020)

6.2.1 United States Non–Invasive Prenatal Testing Market Under COVID-19

6.3 Canada Non–Invasive Prenatal Testing Sales and Growth Rate (2015-2020)

6.4 Mexico Non–Invasive Prenatal Testing Sales and Growth Rate (2015-2020)

7 Europe Non–Invasive Prenatal Testing Market Analysis by Countries

7.1 Europe Non–Invasive Prenatal Testing Sales, Revenue and Market Share by Countries

7.1.1 Europe Non–Invasive Prenatal Testing Sales by Countries (2015-2020)

7.1.2 Europe Non–Invasive Prenatal Testing Revenue by Countries (2015-2020)

7.1.3 Europe Non–Invasive Prenatal Testing Market Under COVID-19

7.2 Germany Non–Invasive Prenatal Testing Sales and Growth Rate (2015-2020)

7.2.1 Germany Non–Invasive Prenatal Testing Market Under COVID-19

7.3 UK Non–Invasive Prenatal Testing Sales and Growth Rate (2015-2020)

7.3.1 UK Non–Invasive Prenatal Testing Market Under COVID-19

7.4 France Non–Invasive Prenatal Testing Sales and Growth Rate (2015-2020)

7.4.1 France Non–Invasive Prenatal Testing Market Under COVID-19

7.5 Italy Non–Invasive Prenatal Testing Sales and Growth Rate (2015-2020)

7.5.1 Italy Non–Invasive Prenatal Testing Market Under COVID-19

7.6 Spain Non–Invasive Prenatal Testing Sales and Growth Rate (2015-2020)

7.6.1 Spain Non–Invasive Prenatal Testing Market Under COVID-19

7.7 Russia Non–Invasive Prenatal Testing Sales and Growth Rate (2015-2020)

7.7.1 Russia Non–Invasive Prenatal Testing Market Under COVID-19

8 Asia-Pacific Non–Invasive Prenatal Testing Market Analysis by Countries

8.1 Asia-Pacific Non–Invasive Prenatal Testing Sales, Revenue and Market Share by Countries

8.1.1 Asia-Pacific Non–Invasive Prenatal Testing Sales by Countries (2015-2020)

8.1.2 Asia-Pacific Non–Invasive Prenatal Testing Revenue by Countries (2015-2020)

8.1.3 Asia-Pacific Non–Invasive Prenatal Testing Market Under COVID-19

8.2 China Non–Invasive Prenatal Testing Sales and Growth Rate (2015-2020)

8.2.1 China Non–Invasive Prenatal Testing Market Under COVID-19

8.3 Japan Non–Invasive Prenatal Testing Sales and Growth Rate (2015-2020)

8.3.1 Japan Non–Invasive Prenatal Testing Market Under COVID-19

8.4 South Korea Non–Invasive Prenatal Testing Sales and Growth Rate (2015-2020)

8.4.1 South Korea Non–Invasive Prenatal Testing Market Under COVID-19

8.5 Australia Non–Invasive Prenatal Testing Sales and Growth Rate (2015-2020)

8.6 India Non–Invasive Prenatal Testing Sales and Growth Rate (2015-2020)

8.6.1 India Non–Invasive Prenatal Testing Market Under COVID-19

8.7 Southeast Asia Non–Invasive Prenatal Testing Sales and Growth Rate (2015-2020)

8.7.1 Southeast Asia Non–Invasive Prenatal Testing Market Under COVID-19

9 Middle East and Africa Non–Invasive Prenatal Testing Market Analysis by Countries

9.1 Middle East and Africa Non–Invasive Prenatal Testing Sales, Revenue and Market Share by Countries

9.1.1 Middle East and Africa Non–Invasive Prenatal Testing Sales by Countries (2015-2020)

9.1.2 Middle East and Africa Non–Invasive Prenatal Testing Revenue by Countries (2015-2020)

9.1.3 Middle East and Africa Non–Invasive Prenatal Testing Market Under COVID-19

9.2 Saudi Arabia Non–Invasive Prenatal Testing Sales and Growth Rate (2015-2020)

9.3 UAE Non–Invasive Prenatal Testing Sales and Growth Rate (2015-2020)

9.4 Egypt Non–Invasive Prenatal Testing Sales and Growth Rate (2015-2020)

9.5 Nigeria Non–Invasive Prenatal Testing Sales and Growth Rate (2015-2020)

9.6 South Africa Non–Invasive Prenatal Testing Sales and Growth Rate (2015-2020)

10 South America Non–Invasive Prenatal Testing Market Analysis by Countries

10.1 South America Non–Invasive Prenatal Testing Sales, Revenue and Market Share by Countries

10.1.1 South America Non–Invasive Prenatal Testing Sales by Countries (2015-2020)

10.1.2 South America Non–Invasive Prenatal Testing Revenue by Countries (2015-2020)

10.1.3 South America Non–Invasive Prenatal Testing Market Under COVID-19

10.2 Brazil Non–Invasive Prenatal Testing Sales and Growth Rate (2015-2020)

10.2.1 Brazil Non–Invasive Prenatal Testing Market Under COVID-19

10.3 Argentina Non–Invasive Prenatal Testing Sales and Growth Rate (2015-2020)

10.4 Columbia Non–Invasive Prenatal Testing Sales and Growth Rate (2015-2020)

10.5 Chile Non–Invasive Prenatal Testing Sales and Growth Rate (2015-2020)

11 Global Non–Invasive Prenatal Testing Market Segment by Types

11.1 Global Non–Invasive Prenatal Testing Sales, Revenue and Market Share by Types (2015-2020)

11.1.1 Global Non–Invasive Prenatal Testing Sales and Market Share by Types (2015-2020)

11.1.2 Global Non–Invasive Prenatal Testing Revenue and Market Share by Types (2015-2020)

11.2 Consumables Sales and Price (2015-2020)
11.3 Reagent Sales and Price (2015-2020)
11.4 Ultrasound Sales and Price (2015-2020)
11.5 NGS Sales and Price (2015-2020)
11.6 PCR Sales and Price (2015-2020)
11.7 Microarray Sales and Price (2015-2020)

12 Global Non–Invasive Prenatal Testing Market Segment by Applications

12.1 Global Non–Invasive Prenatal Testing Sales, Revenue and Market Share by Applications (2015-2020)

12.1.1 Global Non–Invasive Prenatal Testing Sales and Market Share by Applications (2015-2020)

12.1.2 Global Non–Invasive Prenatal Testing Revenue and Market Share by Applications (2015-2020)

12.2 Aneuploidy Sales, Revenue and Growth Rate (2015-2020)
12.3 Microdeletion Sales, Revenue and Growth Rate (2015-2020)

13 Non–Invasive Prenatal Testing Market Forecast by Regions (2020-2026)

13.1 Global Non–Invasive Prenatal Testing Sales, Revenue and Growth Rate (2020-2026)

13.2 Non–Invasive Prenatal Testing Market Forecast by Regions (2020-2026)

13.2.1 North America Non–Invasive Prenatal Testing Market Forecast (2020-2026)

13.2.2 Europe Non–Invasive Prenatal Testing Market Forecast (2020-2026)

13.2.3 Asia-Pacific Non–Invasive Prenatal Testing Market Forecast (2020-2026)

13.2.4 Middle East and Africa Non–Invasive Prenatal Testing Market Forecast (2020-2026)

13.2.5 South America Non–Invasive Prenatal Testing Market Forecast (2020-2026)

13.3 Non–Invasive Prenatal Testing Market Forecast by Types (2020-2026)

13.4 Non–Invasive Prenatal Testing Market Forecast by Applications (2020-2026)

13.5 Non–Invasive Prenatal Testing Market Forecast Under COVID-19

14 Appendix

14.1 Methodology

14.2 Research Data Source

Our Clients

BIC
Suntory Holdings
Continental AG
Ernst Klett
felix
IF Logo
ITC logo
jc
KB
KKR
LR
LSC
Prospect
SRG
Sumitomo
Taichin logo
The Cleanest Way
Meat & Livestock Australia Limited
LEK
IFFCO
STTS
Laundry Capital LLC
Chippenhook Corporation
SAB
IJIN
Hooton
Medica
Medalliacne
Shanghai Chenzhu Instrument Co., Ltd.
Sanofi
Kleen Linnebo und Partner GbR
Bond-Pro, Inc.
E&L Faster Food Imports Inc.
Okinawa Institute of Science and Technology
Mizuno Corp
AutoX

Need Help?

Please fill form below:

Contact Us

99 WALL STREET #2124 NEW YORK, NY 10005